Elkfork Partners’s Insmed INSM Stock Holding History

Elkfork Partners’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-9,702	Closed	-$248K	–	1062
2019 Q2	$248K	Buy	9,702 +8,822	+1,003%	+$246K	0.01%	770
2019 Q1	$26K	Buy	+880	New	+$22.8K	﹤0.01%	1009

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Elkfork Partners's INSM Position: Q3 2019 in Review

Elkfork Partners sold out of Insmed (INSM) in Q3 2019, closing a stake of 9,702 shares — an estimated $248K sold.

Elkfork Partners first reported a position in INSM in Q1 2019 and held it in 2 quarters. The position peaked at $248K in Q2 2019. 157 funds tracked by Wall St. Rank hold INSM as of Q3 2019.

Elkfork Partners reported no remaining Insmed position as of Q3 2019 after selling out during the quarter.
Elkfork Partners sold 9,702 Insmed shares in Q3 2019, an estimated $248K.
Elkfork Partners first reported a position in Insmed in Q1 2019 and held it in 2 quarters.
Elkfork Partners's Insmed position peaked at $248K in Q2 2019.
157 funds tracked by Wall St. Rank held Insmed as of Q3 2019.

Based on Elkfork Partners's 13F filing for Q3 2019, filed 14 Nov 2019.